Icon

VABOMERE (nda209776)- (1GM/VIAL;1GM/VIAL)

MEROPENEM; VABORBACTAM REMPEX
1GM/VIAL;1GM/VIAL
No Yes
2039-Apr-06 2022-Aug-29
None None
2027-Aug-29 No
VABOMERE (meropenem and vaborbactam) is a combination of meropenem, a penem antibacterial, and vaborbactam, a beta-lactamase inhibitor, indicated for the treatment of patients 18 years and older with complicated urinary tract infections (cUTI) including pyelonephritis caused by designated susceptible bacteria.
0 0 0
Total Other Developers 2
Drugs with Suitability No
1GM/VIAL;1GM/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.